Read the latest news from Saama.
Saama’s Gregory T. Simpson Shares Best Practices at Saama PM360 asked 10 life sciences marketing leaders about their favorite (and least favorite) martech in this
PharmaVoice’s “Last Magazine” Features Saama Founder and CEO To celebrate its shift from a monthly magazine to a daily news digest, the PharmaVOICE editorial team
CAMPBELL, CA – (November 19, 2021) – Saama Technologies, LLC. (“Saama”) today announced the appointment of six individuals to its Board of Directors. Saama board
Carlyle and co-investors including Amgen Ventures, Intermountain Ventures, Merck Global Health Innovation Fund (“Merck GHI”), McKesson Ventures, Northpond Ventures, Pfizer Ventures, and Population Health Partners
Private Equity Powerhouse Leads Group of Investors Bullish on AI Leading business publication Forbes broke the news of Saama’s $430 million funding deal with a
Saama’s customized cloud strategy aligned with AWS Saama Smart Applications for fast-tracked clinical innovation supported by AWS Saama ensures faster, safer clinical development via AWS
AI Is More than Just Business Process Efficiency In this forward-looking article, Saama’s Jonathan Burr, Senior VP, Clinical Platform Strategy, shows how AI is informing
An Interview with Suresh Katta Saama’s Founder and CEO, Suresh Katta, sat down with Outsourcing-Pharma for a fascinating interview about the digital transformation of the
Digital Transformation Included a Focus on Data Quality This article from Analytics Insight explains how Pfizer’s willingness to embrace digital transformation and artificial intelligence (AI)
